2 completed, 2 terminated. 2 Phase 2, 2 Phase 3, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Completed 1, Terminated 1 |
| Phase 3 | 2 | Completed 1, Terminated 1 |
| Phase 1 | 1 | Completed 1 |
Follow Neuropharm: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Extended Management and Measurement of Autism Fluoxetine (prozac) - Autistic Disorder | Phase 3 | Terminated | Neuropharm | 128 | 2008-11-01 | 2010-02-23 |
| Open Label Study Investigating Safety and Efficacy of NPL2009 50 mg - 150 mg on Prepulse Inhibition Tests and Continuous Performance Tasks, Adults With Fragile X Syndrome NPL-2009 - Fragile X Syndrome | Phase 1 / Phase 2 | Completed | Neuropharm | 12 | 2008-03-01 | 2012-04-27 |
| Study of Fluoxetine in Autism Fluoxetine, Placebo - Autistic Disorder | Phase 3 | Completed | Neuropharm | 158 | 2007-08-01 | 2012-04-27 |
| Study of NPL-2003 in Adolescents With Obsessive Compulsive Disorder (OCD) Minocycline - Obsessive Compulsive Disorder | Phase 2 | Terminated | Neuropharm | 6 | 2007-07-01 | 2012-04-27 |
Autistic Disorder (2) · Fragile X Syndrome (1) · Obsessive-Compulsive Disorder (1)
Fluoxetine (2) · Minocycline (1)
United States (4)
Mike Snape, PhD (1)